Dysregulated DAT is associated with neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) (Volkow et al., 2007; Nakamura et al., 2010; Makkonen et al., 2011; Spencer et al., 2013). Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.